A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 6, 2000, Pages 1127-1140

  Calderone, Angelino ^a   Abdelaziz, Nadia ^a   Colombo, Federico ^a   Schreiber, Kathy L ^a   Rindt, Hansjörg ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Calmodulin; Farnesyltransferase inhibitor; G protein coupled receptors; Gene expression; Myocyte hypertrophy; ras

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BMS 191563; ENDOTHELIN 1; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NORADRENALIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033849521     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1150     Document Type: Article

References (45)

1. Postnatal muscle fiber assembly: Localization of newly synthesized myofibrillar proteins
2. Biochemical correlates of cardiac hypertrophy. 1. Experimental model; changes in heart weight, RNA content, and nuclear polymerase activity
3. Myosin isoenzymatic changes in several models of cardiac hypertrophy
4. The vascular smooth muscle α-actin is reactivated during cardiac hypertrophy provoked by load
5. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNA's
6. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiological response
7. Wall stress and patterns of hypertrophy in the human left ventricle
8. Signaling pathways in cardiac myocyte hypertrophy
9. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype
10. The tyrosine kinase inhibitor, genistein, prevents α-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway
11. Ras and Rho are required for Gαq-induced hypertrophic gene expression in neonatal rat cardiac myocytes
12. Hras-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy
13. Oncogenic src, raf, and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes
14. Cell calcium, oncogenes, and hypertrophy
15. The α-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways
16. Nitric oxide, atrial natriuretic factor, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
17. +-ATPase to growth-related genes in cardiac myocytes
18. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
19. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes
20. Targeted overexpression of calmodulin induces pro-liferative and hypertrophic growth of cardio-myocytes in transgenic mice
21. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an α-adrenergic response
22. Altered protein kinase C regulation of phosphoinositide-coupled receptors in deoxycorticosterone acetate-salt hypertensive rats
23. Cardiac-specific overexpression of α(1B)AR regulates βAR activity via molecular crosstalk
24. Single step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction
25. The regulation of tyrosine kinase signaling pathways by growth factor and G-protein-coupled receptors
26. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo
27. Atrial natriuretic factor: A molecular marker for cardiac specific, embryonic, and inducible gene expression
28. Regulation of ras-GTP loading and ras-raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester
29. Differential effects of protein kinase C, ras, and raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal M-CAT element
30. Interleukin-1β regulation of the human brain natriuretic peptide promoter involves ras-, rac-, and p38 kinase-dependent pathways in cardiac myocytes
31. Endothelin ET(A) receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways
32. C-terminal motifs found in ras-superfamily G-proteins: CAAX and C-seven motifs
33. Farnesyltransferase inhibitors: A new class of cancer chemotherapeutics
34. Farnesyltransferase inhibitors block the neurofibromatosis type I malignant phenotype
35. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes: The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy
36. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes
37. 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes
38. Role of the stress-activated protein kinases in endothelin-induced cardio-myocyte hypertrophy
39. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts
40. 1-adrenergic receptor and ran activation and is associated with in vitro and in vivo cardiac hypertrophy
41. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade in cardiac hypertrophy
42. The heterotrimeric G(q) protein-coupled angiotensin II receptor activates p21(ras) via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes
43. 2+-dependent signaling
44. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells
45. Ventricular expression of the MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice